|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Eu Yan Sang International Ltd
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Eu Yan Sang International Ltd Headquarters 269A, South Bridge Road; Singapore; Singapore; 058818 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : SG1I87884967 Financial Auditors: Ernst & Young (2002) Incorporation Date: April 10, 1993 Total Employees: 927 Tel: (65) 6225 3211 |
|
Company Description |
| The principal activities of the Company are investment holding and the provision of management services to the Group. Today, the company manufactures and markets fine quality, Chinese herbs, Chinese Proprietary Medicines as well as health foods. Eu Yan Sang manufactures and markets fine quality Chinese herbs, Chinese Proprietary Medicines as well as health foods. Eu Yan Sang currently offers more than 250 products under its Eu Yan Sang brand name and over 1,000 different types of Chinese herbs and | ||
|
||
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
FULL COMPANY PROFILE
|
|
2013 Q3 (cons) |
2012 Y (cons) |
|
 | ||
| Non-Audited | Audited | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
XXX |
XXX |
| ||
Current Assets |
XXX |
XXX |
| ||
Total Liabilities |
XXX |
XXX |
| ||
Shareholders Equity |
XXX |
XXX |
| ||
Current Liabilities |
XXX |
XXX |
| ||
| * All the accounts are in SGD. | ||
Income Statement
| ||
Total Operating Revenue |
XXX |
XXX |
| ||
Operational Profit (Loss) |
XXX |
XXX |
| ||
Net Profit (Loss) |
XXX |
XXX |
| ||
| * All the accounts are in SGD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
XXX |
XXX |
| ||
Annualised Return on Assets (ROA) |
XXX |
XXX |
| ||
Return on Equity (ROE) |
XXX |
XXX |
| ||
Annualised Return on Equity (ROE) |
XXX |
XXX |
| ||
Return on Sales (ROS) |
XXX |
XXX |
| ||
Return on Capital |
XXX |
XXX |
| ||
Gross Profit Margin |
XXX |
XXX |
| ||
Operating Profit Margin |
XXX |
XXX |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
XXX |
XXX |
| ||
Inventory Turnover |
XXX |
XXX |
| ||
Current asset turnover |
XXX |
XXX |
| ||
Fixed-asset turnover |
XXX |
XXX |
| ||
Asset Turnover |
XXX |
XXX |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
XXX |
XXX |
| ||
EBITDA |
XXX |
XXX |
| ||
Enterprise value |
XXX |
XXX |
| ||
Enterprise Value / EBITDA |
XXX |
XXX |
| ||
Bookvalue (BV) |
XXX |
XXX |
| ||
Net Cash |
XXX |
XXX |
| Liquidity Ratios | ||
| ||
Current Ratio |
XXX |
XXX |
| ||
Quick ratio |
XXX |
XXX |
| ||
Doom's day ratio |
XXX |
XXX |
| Leverage Ratios | ||
| ||
Leverage ratio |
XXX |
XXX |
| ||
Interest Coverage Ratio |
XXX |
XXX |
| ||
Debt to equity |
XXX |
XXX |
| ||
Debt to total assets |
XXX |
XXX |
| ||
Long Term Debt to Capital |
XXX |
XXX |
| ||
Debt / Enterprise Value |
XXX |
XXX |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
XXX |
XXX |
| ||
Price/Book Ratio |
XXX |
XXX |
| ||
Market Cap / Net cash |
XXX |
XXX |
| Trend Ratios | ||
| ||
Revenue Trend |
XXX |
XXX |
| ||
Net Income Trend |
XXX |
XXX |
| ||
Operating Income Trend |
XXX |
XXX |
| ||
 |